Chronic enteropathy associated with SLCO2A1 gene

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:468641K63.8
Who is this for?
Show terms as
8Treatment centers1Financial resources

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Chronic enteropathy associated with SLCO2A1 gene (also known as CEAS or chronic nonspecific multiple ulcers of the small intestine, CNSU) is a rare inherited digestive disorder caused by mutations in the SLCO2A1 gene. This gene provides instructions for making a protein that helps transport prostaglandins, which are important chemical messengers involved in inflammation and tissue repair in the gut lining. When this transporter does not work properly, prostaglandins build up in the intestinal wall, leading to chronic inflammation and the formation of multiple ulcers, primarily in the small intestine. Patients typically experience persistent or recurring abdominal pain, chronic diarrhea, blood in the stool, and iron-deficiency anemia that does not respond well to standard treatments. Over time, the ongoing blood loss and poor nutrient absorption can lead to significant weight loss, fatigue, and protein deficiency. Some patients may also develop thickening of the fingers (digital clubbing) and small bowel strictures that can cause intestinal obstruction. There is currently no cure for this condition. Treatment focuses on managing symptoms, correcting anemia with iron supplements or transfusions, ensuring adequate nutrition, and sometimes using medications to reduce inflammation. In severe cases where strictures or blockages develop, surgery may be needed to remove damaged sections of the intestine. The condition was initially described predominantly in East Asian populations, particularly in Japan, though cases have been identified in other regions as well.

Also known as:

Key symptoms:

Chronic or recurring abdominal painPersistent diarrheaBlood in the stool (visible or hidden)Iron-deficiency anemia that does not improve with standard treatmentUnexplained weight lossChronic fatigue and weaknessLow protein levels in the blood (hypoalbuminemia)Swelling in the legs or feet due to low proteinThickening or clubbing of the fingertipsMultiple small intestine ulcersNarrowing of the small intestine (strictures)Episodes of intestinal blockagePoor appetiteNausea

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Chronic enteropathy associated with SLCO2A1 gene.

View clinical trials →

No actively recruiting trials found for Chronic enteropathy associated with SLCO2A1 gene at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Chronic enteropathy associated with SLCO2A1 gene community →

No specialists are currently listed for Chronic enteropathy associated with SLCO2A1 gene.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Financial Resources

1 resources

Cuvposa

Shionogi, Inc.

Cuvposa — Contact Shionogi, Inc.

Unverified — confirm before calling
Patient Assistance
Manufacturer Program
Accepting applications

Travel Grants

No travel grants are currently matched to Chronic enteropathy associated with SLCO2A1 gene.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Chronic enteropathy associated with SLCO2A1 geneForum →

No community posts yet. Be the first to share your experience with Chronic enteropathy associated with SLCO2A1 gene.

Start the conversation →

Latest news about Chronic enteropathy associated with SLCO2A1 gene

No recent news articles for Chronic enteropathy associated with SLCO2A1 gene.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What is the current severity of my intestinal disease, and how many ulcers or strictures are present?,How often should I have blood tests and imaging to monitor my condition?,What are the best options for managing my anemia and nutritional deficiencies?,Are there any new or experimental treatments being studied for this condition?,What warning signs should prompt me to seek emergency care?,Should my family members be tested for carrier status of the SLCO2A1 gene mutation?,What dietary changes can help me manage my symptoms and improve my nutrition?

Common questions about Chronic enteropathy associated with SLCO2A1 gene

What is Chronic enteropathy associated with SLCO2A1 gene?

Chronic enteropathy associated with SLCO2A1 gene (also known as CEAS or chronic nonspecific multiple ulcers of the small intestine, CNSU) is a rare inherited digestive disorder caused by mutations in the SLCO2A1 gene. This gene provides instructions for making a protein that helps transport prostaglandins, which are important chemical messengers involved in inflammation and tissue repair in the gut lining. When this transporter does not work properly, prostaglandins build up in the intestinal wall, leading to chronic inflammation and the formation of multiple ulcers, primarily in the small int

How is Chronic enteropathy associated with SLCO2A1 gene inherited?

Chronic enteropathy associated with SLCO2A1 gene follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

What treatment and support options exist for Chronic enteropathy associated with SLCO2A1 gene?

1 patient support program are currently tracked on UniteRare for Chronic enteropathy associated with SLCO2A1 gene. See the treatments and support programs sections for copay assistance, eligibility, and contact details.